Paraoxonase 1 attenuates human plaque atherogenicity: relevance to the enzyme lactonase activity.
Human atherosclerotic lesions contain a variety of lipids and oxidized lipids, which can induce atherogenic properties such as macrophage oxidation, lipoprotein oxidation and inhibition of cholesterol efflux from macrophages. These atherogenic properties of the plaque's lipid fraction are associated with the inhibition of paraoxonase 1 (PON1) lactonase activity. In contrast, incubation of PON1 with the plaque's lipid fraction reduces the lesion's atherogenic properties by lowering the capacity of the oxidized lipids to induce further oxidation. The mechanism of PON1's protective action and its endogenous substrate however remain elusive. Modeling studies may characterize PON1's possible active site, and help envisage the structure of potential endogenous and exogenous lactones as PON1 ligands. Such modeling thus may lead to a better understanding of PON1's anti-atherogenic mechanism of action.
Tavori
Hagai
H
The Lipid Research Laboratory, Technion Faculty of Medicine, Rappaport Family Institute for Research in the Medical Science and Rambam Medical Center, 31096, Haifa, Israel. hagait@migal.org.il
Vaya
Jacob
J
Aviram
Michael
M
D043303:Aryldialkylphosphatase / Q000737:chemistry / Q000378:metabolism*; D050197:Atherosclerosis / Q000378:metabolism*; D002339:Carotid Arteries / Q000473:pathology; D020134:Catalytic Domain; D006801:Humans; D007783:Lactones / Q000737:chemistry / Q000378:metabolism*; D008264:Macrophages / Q000201:enzymology; D008954:Models, Biological; D008956:Models, Chemical; D008958:Models, Molecular; D018384:Oxidative Stress; D010100:Oxygen / Q000737:chemistry; D058226:Plaque, Atherosclerotic; D011487:Protein Conformation
D007783:Lactones; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human; D010100:Oxygen